These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 15648965)

  • 41. Fabry disease--a primer for cardiologists.
    Mursă A; Ginghină C; Jurcut R
    Rom J Intern Med; 2014; 52(4):216-22. PubMed ID: 25726623
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Fabry's disease: diagnosis in the pediatric age group].
    Pintos Morell G
    An Esp Pediatr; 2002 Jul; 57(1):45-50. PubMed ID: 12139892
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Association of renal ectopia with Fabry's disease in 3 patients.
    Rákóczi E; Tóth B; Görögh S; Erdos M; Sümegi J; Maródi L
    J Urol; 2009 Apr; 181(4):1949-54. PubMed ID: 19237168
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Anderson-Fabry disease].
    Kes P; Basić-Jukić N; Brunetta B; Jurić I
    Acta Med Croatica; 2006; 60(1):55-8. PubMed ID: 16802573
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Cardiac Fabry's disease: an unusual cause of left ventricular hypertrophy.
    Nunes JP; Costa O; Faria Mdo S; Almeida PB; Lacerda L
    Nat Clin Pract Cardiovasc Med; 2007 Nov; 4(11):630-3. PubMed ID: 17957210
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Cardiac manifestations in Fabry disease].
    Lappegård KT; Aass H
    Tidsskr Nor Laegeforen; 2000 Aug; 120(20):2395-6. PubMed ID: 11475223
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [End-stage cardiac manifestations and autopsy findings in patients with cardiac fabry disease].
    Teraguchi H; Takenaka T; Yoshida A; Taguchi S; Ninomiya K; Yoshida H; Horinouchi M; Yonezawa S; Nakao S; Minagoe S; Tei S
    J Cardiol; 2004 Feb; 43(2):98-9. PubMed ID: 15046052
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Long-term effects of enzyme replacement therapy on fabry cardiomyopathy: evidence for a better outcome with early treatment.
    Weidemann F; Niemann M; Breunig F; Herrmann S; Beer M; Störk S; Voelker W; Ertl G; Wanner C; Strotmann J
    Circulation; 2009 Feb; 119(4):524-9. PubMed ID: 19153271
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Cardiac performance during exercise in patients with Fabry's disease.
    Spinelli L; Nicolai E; Acampa W; Imbriaco M; Pisani A; Rao MA; Scopacasa F; Cianciaruso B; De Luca N; Cuocolo A
    Eur J Clin Invest; 2008 Dec; 38(12):910-7. PubMed ID: 19021715
    [TBL] [Abstract][Full Text] [Related]  

  • 50. MRI characterization of myocardial tissue in patients with Fabry's disease.
    Imbriaco M; Spinelli L; Cuocolo A; Maurea S; Sica G; Quarantelli M; Pisani A; Liuzzi R; Cianciaruso B; Sabbatini M; Salvatore M
    AJR Am J Roentgenol; 2007 Mar; 188(3):850-3. PubMed ID: 17312078
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Update on Fabry disease: kidney involvement, renal progression and enzyme replacement therapy.
    Breunig F; Wanner C
    J Nephrol; 2008; 21(1):32-7. PubMed ID: 18264934
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Cardiac manifestations of Anderson-Fabry disease in children and adolescents.
    Kampmann C; Wiethoff CM; Whybra C; Baehner FA; Mengel E; Beck M
    Acta Paediatr; 2008 Apr; 97(4):463-9. PubMed ID: 18363956
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Transvenous permanent pacemaker implantation for Fabry's disease. 3 cases report].
    Yoshida K; Murase M; Maseki T; Usui A; Ina H; Abe T
    Nihon Kyobu Geka Gakkai Zasshi; 1989 Feb; 37(2):386-90. PubMed ID: 2504843
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Renal involvement in Fabry disease].
    Kaaroud H; Béji S; Boubaker K; Ben Moussa F; Ben Hamida F; Goucha R; Ben Dridi MF; Ben Turkia H; Kheder A
    Tunis Med; 2007 Mar; 85(3):240-3. PubMed ID: 17668583
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Cardiac challenges in patients with Fabry disease.
    Weidemann F; Linhart A; Monserrat L; Strotmann J
    Int J Cardiol; 2010 May; 141(1):3-10. PubMed ID: 19720409
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Department-related tasks and organ-targeted therapy in Fabry disease: an interdisciplinary challenge.
    Weidemann F; Sommer C; Duning T; Lanzl I; Möhrenschlager M; Naleschinski D; Arning K; Baron R; Niemann M; Breunig F; Schaefer R; Strotmann J; Wanner C
    Am J Med; 2010 Jul; 123(7):658.e1-658.e10. PubMed ID: 20609689
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Complete atrioventricular block disclosing Fabry's disease].
    Elhadad S; Melet V; Domniez T; Cosson S; Chollet D; Vedel J
    Arch Mal Coeur Vaiss; 1997 Mar; 90(3):393-7. PubMed ID: 9232078
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Decline of plasma brain natriuretic peptide during enzyme replacement therapy in a female patient with heterozygous Fabry's disease.
    Masugata H; Senda S; Goda F; Yamagami A; Okuyama H; Kohno T; Hosomi N; Yukiiri K; Noma T; Murao K; Kohno M; Itoh S
    Tohoku J Exp Med; 2009 Mar; 217(3):169-74. PubMed ID: 19282651
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Adult polyglucosan body disease in a patient originally diagnosed with Fabry's disease.
    Sagnelli A; Savoiardo M; Marchesi C; Morandi L; Mora M; Morbin M; Farina L; Mazzeo A; Toscano A; Pagliarani S; Lucchiari S; Comi GP; Salsano E; Pareyson D
    Neuromuscul Disord; 2014 Mar; 24(3):272-6. PubMed ID: 24380807
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Fabry disease].
    Feriozzi S; Faraggiana T
    G Ital Nefrol; 2005; 22 Suppl 33():S34-8. PubMed ID: 16419004
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.